- The role of SPP1 in MASLD pathogenesis: Therapeutic insights into ursolic acid’s mechanisms of action: Correspondence to editorial on “Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease”
-
Zheng Y, Xiong Z, Zhao L, Huang C, Yong Q, Fang D, Liu F, Li Y
- KMID: 2560114
- Clin Mol Hepatol.
- 2024 Oct;30(4):1019-1022.
- doi: 10.3350/cmh.2024.0471
-
- CITED
-
- Close
- SHARE
-
- Close
- Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease
-
Zheng Y, Zhao L, Xiong Z, Huang C, Yong Q, Fang D, Fu Y, Gu S, Chen C, Li J, Zhu Y, Liu J, Liu F, Li Y
- KMID: 2557395
- Clin Mol Hepatol.
- 2024 Jul;30(3):449-467.
- doi: 10.3350/cmh.2024.0047
Background/Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become an increasingly important health challenge, with a substantial rise linked to changing lifestyles and global obesity. Ursolic acid, a natural pentacyclic... -
- CITED
-
- Close
- SHARE
-
- Close
